Abstract

GM-CSF in the treatment of COVID-19: a new conductor in the pathogenesis of cytokine storm?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The immunology of COVID-19: is immune modulation an option for treatment?
Jixin Zhong ... Lingli Dong
The Lancet Rheumatology | VOL. 2
Jixin Zhong, et. al.Jixin Zhong ... Lingli Dong
20 May 2020
Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations
Fabio Angeli ... Paolo Verdecchia
European Journal of Internal Medicine | VOL. 95
Fabio Angeli, et. al.Fabio Angeli ... Paolo Verdecchia
14 Oct 2021
COVID-19 vasculitis and novel vasculitis mimics.
Dennis Mcgonagle ... Athimalaipet V Ramanan
The Lancet Rheumatology | VOL. 3
Dennis Mcgonagle, et. al.Dennis Mcgonagle ... Athimalaipet V Ramanan
07 Jan 2021
Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?
Gaetano Zizzo ... Philip L Cohen
The Lancet Rheumatology | VOL. 2
Gaetano Zizzo, et. al.Gaetano Zizzo ... Philip L Cohen
09 Oct 2020
View more papers

More From: The Lancet Rheumatology

Paper Title
Journal
Date
Author
Proliferative features of IgG4-related disease.
Guy Katz ... Diego Palumbo
The Lancet Rheumatology | VOL. 6
Guy Katz, et. al.Guy Katz ... Diego Palumbo
01 Jul 2024
Welcome new evidence on self-management of back pain.
Chris Maher ... Chung-Wei Christine Lin
The Lancet Rheumatology | VOL. 6
Chris Maher, et. al.Chris Maher ... Chung-Wei Christine Lin
01 Jul 2024
Contesting the BACPAP consortium's consensus - Authors' reply.
Eva Kosek ... Steven Z George
The Lancet Rheumatology | VOL. 6
Eva Kosek, et. al.Eva Kosek ... Steven Z George
01 Jul 2024
Systemic lupus erythematosus: managing cardiovascular risk factors
Anisur Rahman
The Lancet Rheumatology | VOL. 6
Anisur RahmanAnisur Rahman
01 Jul 2024
View more papers